Pharmacokinetics of Liposomal Amphotericin B in Critically Ill vs. Non-critically Ill Hematological Patients: Exploration of Covariates
Sponsor: KU Leuven
This observational or N/A phase trial investigates Critically Ill Patients and Liposomal Amphotericin B and is currently actively recruiting participants. KU Leuven leads this study, which shows 10 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Aug 2024 — Sep 2024 [monthly]
Recruiting
Status: Unknown → Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Nov 2022 — Jul 2024 [monthly]
Unknown Status
-
Dec 2021 — Nov 2022 [monthly]
Unknown Status
▶ Show 5 earlier versions
-
Feb 2021 — Dec 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Feb 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Aug 2018 — Nov 2020 [monthly]
Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Recruiting
First recorded
Oct 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- KU Leuven
- Universitaire Ziekenhuizen KU Leuven
For direct contact, visit the study record on ClinicalTrials.gov .